Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

B109

Sigma-Aldrich

nor-Binaltorphimine dihydrochloride

solid

Synonym(s):

nor-BNI dihydrochloride

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C40H43N3O6 · 2HCl
CAS Number:
113158-34-2
Molecular Weight:
734.71
MDL number:
MFCD00069374
UNSPSC Code:
12352103
PubChem Substance ID:
329773161

form

solid

color

tan

solubility

artificial CSF: 2 mg/mL (prepare with sonication for 4 minutes)
H2O: 6.0 mg/mL (aqueous solutions are highly unstable and should be freshly prepared.)
ethanol: soluble

SMILES string

Cl[H].Cl[H].Oc1ccc2C[C@H]3N(CC[C@@]45[C@@H](Oc1c24)c6[nH]c7[C@@H]8Oc9c(O)ccc%10C[C@H]%11N(CC[C@@]8(c9%10)[C@@]%11(O)Cc7c6C[C@@]35O)CC%12CC%12)CC%13CC%13

InChI

1S/C40H43N3O6.2ClH/c44-25-7-5-21-13-27-39(46)15-23-24-16-40(47)28-14-22-6-8-26(45)34-30(22)38(40,10-12-43(28)18-20-3-4-20)36(49-34)32(24)41-31(23)35-37(39,29(21)33(25)48-35)9-11-42(27)17-19-1-2-19;;/h5-8,19-20,27-28,35-36,41,44-47H,1-4,9-18H2;2*1H/t27-,28-,35+,36+,37+,38+,39-,40-;;/m1../s1

InChI key

JOJPJLHRMGPDPV-LZQROVCBSA-N

Looking for similar products? Visit Product Comparison Guide

Biochem/physiol Actions

Highly selective κ-opioid receptor antagonist.

replaced by

Product No.
Description
Pricing

Storage Class Code

13 - Non Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

S A Hjorth et al.
Molecular pharmacology, 47(6), 1089-1094 (1995-06-01)
The structural determinants for the selective binding of the nonpeptide opioid receptor antagonist nor-binaltorphimine (nor-BNI) to the kappa-opioid receptor were characterized using a systematic series of chimeras between the kappa receptor and the homologous mu-opioid receptor. All 10 chimeric constructs
M C Ko et al.
The Journal of pharmacology and experimental therapeutics, 291(3), 1113-1120 (1999-11-24)
Systemic administration of nor-binaltorphimine (nor-BNI) produces a long-lasting kappa-opioid receptor (kappaOR) antagonism and has kappa(1)-selectivity in nonhuman primates. The aim of this study was to establish the pharmacological basis of central kappaOR antagonism in rhesus monkeys (Macaca mulatta). After intracisternal
A E Takemori et al.
The Journal of pharmacology and experimental therapeutics, 246(1), 255-258 (1988-07-01)
Previously, we reported on an opioid antagonist, nor-binaltorphimine (nor-BNI), that had high selectivity for kappa opioid receptors in smooth muscle preparations. In this study, nor-BNI administered either s.c. or i.c.v. was shown to antagonize significantly the antinociceptive effects of the
N P Bondar'
Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova, 98(6), 681-692 (2012-09-28)
Mu and kappa opioid receptors often show opposite actions in the regulation ofphysiological functions and behaviors including aggressive behavior. In the present study, effects ofmu antagonist CTAP (1 and 2 mg/kg, sc) and kappa antagonist nor-BNI (0.5 mg/kg, sc) on
Juliana Almeida da Silva et al.
European journal of pharmacology, 698(1-3), 235-245 (2013-02-12)
The chemical neuroanatomy and the effects of central administration of opioid antagonists on the innate fear-induced responses elicited by electrical (at escape behaviour threshold) stimulation of the midbrain tectum were determined. The aim of the present work was to investigate
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service